Healthcare - Biotechnology - NASDAQ - US
$ 55.13
-3.9 %
$ 9.27 B
Market Cap
-15.06
P/E
Price Target
Average
4.00%
Revenue Forecast
Estimate
167.10%
EBIT
Estimate
--4.88%
Net Income
Estimate
18.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Revolution Medicines, Inc.
Wall Street analysts predict an average 1-year price target for RVMD of $57.3 , with forecasts ranging from a low of $43 to a high of $82 .
RVMD Lowest Price Target
Wall Street Target
43 USD
-22.00%
RVMD Average Price Target
Wall Street Target
57.3 USD
4.00%
RVMD Highest Price Target
Wall Street Target
82 USD
48.74%
REVENUE FORECAST
Revenue Forecast Chart RVMD
EBIT FORECAST
EBIT Forecast Chart RVMD
NET INCOME FORECAST
Net Income Chart RVMD